ArticleiScience2024

Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer.

Jiayi Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.